These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 3663154)
41. Biliary copper excretion by hepatocyte lysosomes in the rat. Major excretory pathway in experimental copper overload. Gross JB; Myers BM; Kost LJ; Kuntz SM; LaRusso NF J Clin Invest; 1989 Jan; 83(1):30-9. PubMed ID: 2910913 [TBL] [Abstract][Full Text] [Related]
42. Bile acid structure and biliary secretion of cholesterol and phospholipid in the cat. Smallwood RA; Hoffman NE Gastroenterology; 1976 Dec; 71(6):1064-6. PubMed ID: 992268 [TBL] [Abstract][Full Text] [Related]
43. Isolation and biochemical analysis of vesicles from taurohyodeoxycholic acid-infused isolated perfused rat livers. Hismiogullari AA; Hismiogullari SE; Rahman K World J Gastroenterol; 2013 Oct; 19(37):6228-36. PubMed ID: 24115821 [TBL] [Abstract][Full Text] [Related]
44. Increase in serum and bile cholesterol and HMG-CoA reductase by lovastatin in rats. Yamauchi S; Linscheer WG; Beach DH Am J Physiol; 1991 Apr; 260(4 Pt 1):G625-30. PubMed ID: 2018137 [TBL] [Abstract][Full Text] [Related]
45. Mechanism and kinetic characteristics of the uncoupling by plant steroids of biliary cholesterol from bile salt output. Ulloa N; Nervi F Biochim Biophys Acta; 1985 Nov; 837(2):181-9. PubMed ID: 4052446 [TBL] [Abstract][Full Text] [Related]
46. Influence of acute injection of chloroquine on the biliary secretion of lipids and lysosomal enzyme on rats. Lafont H; Chanussot F; Dupuy C; Lechene P; Lairon D; Charbonnier-Augeire M; Chabert C; Portugal H; Pauli AM; Hauton JC Lipids; 1984 Mar; 19(3):195-201. PubMed ID: 6717251 [TBL] [Abstract][Full Text] [Related]
47. Effects of chronic choleretic infusions of bile acids on the membrane of the bile canaliculus. A biochemical and morphologic study. Nemchausky BA; Layden TJ; Boyer JL Lab Invest; 1977 Mar; 36(3):259-67. PubMed ID: 138767 [TBL] [Abstract][Full Text] [Related]
48. Partial characterization of regulation of biliary lecithin hydrophobicity: association with organic anion-induced solute cholestasis in rats. Miura H; Tazuma S; Kajiyama G Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):795-7. PubMed ID: 8554522 [TBL] [Abstract][Full Text] [Related]
49. Enhancement of bile acid-induced biliary lipid secretion by streptozotocin in rats: role of insulin deficiency. Villanueva GR; Herreros M; Perez-Barriocanal F; Bolaños JP; Bravo P; Marin JJ J Lab Clin Med; 1990 Apr; 115(4):441-8. PubMed ID: 2139093 [TBL] [Abstract][Full Text] [Related]
50. Effects of oleic acid on the biosynthesis of lipoprotein apoproteins and distribution into the very-low-density lipoprotein by the isolated perfused rat liver. Salam WH; Wilcox HG; Heimberg M Biochem J; 1988 May; 251(3):809-16. PubMed ID: 3166373 [TBL] [Abstract][Full Text] [Related]
51. Modulation of biliary lipid secretion by forskolin and cyclic AMP analogues. Hamlin S; Rahman K; Carrella M; Coleman R Biochem J; 1990 Feb; 265(3):879-85. PubMed ID: 2154971 [TBL] [Abstract][Full Text] [Related]
52. The mechanism of increased biliary lipid secretion in mice with genetic inactivation of bile salt export pump. Gooijert KE; Havinga R; Wolters H; Wang R; Ling V; Tazuma S; Verkade HJ Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(5):G450-7. PubMed ID: 25552583 [TBL] [Abstract][Full Text] [Related]
53. Hepatic uptake and processing of free cholesterol from different lipoproteins with and without sodium taurocholate administration. An in vivo study in the rat. Bravo E; Cantafora A Biochim Biophys Acta; 1990 Jun; 1045(1):74-80. PubMed ID: 2369587 [TBL] [Abstract][Full Text] [Related]
54. Ticlopidine, a cholestatic liver injury-inducible drug, causes dysfunction of bile formation via diminished biliary secretion of phospholipids: involvement of biliary-excreted glutathione-conjugated ticlopidine metabolites. Yoshikado T; Takada T; Yamamoto H; Tan JK; Ito K; Santa T; Suzuki H Mol Pharmacol; 2013 Feb; 83(2):552-62. PubMed ID: 23220748 [TBL] [Abstract][Full Text] [Related]
55. Effects of obesity on bile formation and biliary lipid secretion in the genetically obese JCR:LA-corpulent rat. St George CM; Russell JC; Shaffer EA Hepatology; 1994 Dec; 20(6):1541-7. PubMed ID: 7982654 [TBL] [Abstract][Full Text] [Related]
56. Enrichment of canalicular membrane with cholesterol and sphingomyelin prevents bile salt-induced hepatic damage. Amigo L; Mendoza H; Zanlungo S; Miquel JF; Rigotti A; González S; Nervi F J Lipid Res; 1999 Mar; 40(3):533-42. PubMed ID: 10064742 [TBL] [Abstract][Full Text] [Related]
57. Biliary lipid secretion during the prereplicative phase of rat liver regeneration. Perez-Barriocanal F; Perez-Antona JC; Regueiro P; Villanueva GR; Marin JJ J Exp Pathol (Oxford); 1990 Feb; 71(1):63-8. PubMed ID: 2310616 [TBL] [Abstract][Full Text] [Related]
58. Fractionation of livers following diosgenin treatment to elevate biliary cholesterol. Roman ID; Thewles A; Coleman R Biochim Biophys Acta; 1995 Mar; 1255(1):77-81. PubMed ID: 7893741 [TBL] [Abstract][Full Text] [Related]
59. Effect of diosgenin on biliary cholesterol transport in the rat. Thewles A; Parslow RA; Coleman R Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):793-8. PubMed ID: 8387778 [TBL] [Abstract][Full Text] [Related]
60. Inhibition of biliary phospholipid and cholesterol secretion by cefoperazone. Pattinson NR; Willis KE; Chapman BA Dig Dis Sci; 1987 Jun; 32(6):615-9. PubMed ID: 3568949 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]